Daan van der Noort, MD

Daan van den Noort has an extensive track record in the biotech industry and a lot of experience with financing of start-ups. He was partner of a venture capital organization and is currently board member of the biotech company Bioseutica. Daan van den Noort will advise CiMaas on subjects of business development, financing and strategy.

Alexander Vos, MSc, MBA

Alexander Vos is an Experienced Chief Executive Officer, Board member and investor with a successful track-record in the biopharmaceuticals industry, notably in orphan and rare diseases and Cell & Gene Therapy. Skilled in Strategy Development, Investor Relations, Operations Management, Biotechnology, Licensing and M&A, and Marketing.